The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: tenofovir     Quarter: 2016Q3

Total Records: 439     Number of Pages: 22

DRUGNAME PT EventCount
TENOFOVIR DISOPROXIL FUMARATE. Metabolic syndrome 1
TENOFOVIR DISOPROXIL FUMARATE. Metastases to lung 1
TENOFOVIR DISOPROXIL FUMARATE. Myalgia 1
TENOFOVIR DISOPROXIL FUMARATE. Myocardial infarction 1
TENOFOVIR DISOPROXIL FUMARATE. Myocarditis infectious 1
TENOFOVIR DISOPROXIL FUMARATE. Nephropathy 1
TENOFOVIR DISOPROXIL FUMARATE. Nervous system disorder 1
TENOFOVIR DISOPROXIL FUMARATE. Neurotoxicity 1
TENOFOVIR DISOPROXIL FUMARATE. Neutrophil count decreased 1
TENOFOVIR DISOPROXIL FUMARATE. Non-Hodgkin's lymphoma 1
TENOFOVIR DISOPROXIL FUMARATE. Obesity 1
TENOFOVIR DISOPROXIL FUMARATE. Pancytopenia 1
TENOFOVIR DISOPROXIL FUMARATE. Plagiocephaly 1
TENOFOVIR DISOPROXIL FUMARATE. Pleural effusion 1
TENOFOVIR DISOPROXIL FUMARATE. Pneumocystis jirovecii pneumonia 1
TENOFOVIR DISOPROXIL FUMARATE. Polydactyly 1
TENOFOVIR DISOPROXIL FUMARATE. Portal hypertension 1
TENOFOVIR DISOPROXIL FUMARATE. Pulmonary fibrosis 1
TENOFOVIR DISOPROXIL FUMARATE. Pyrexia 1
TENOFOVIR DISOPROXIL FUMARATE. Raynaud's phenomenon 1

Total Records: 439     Number of Pages: 22